| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $110.2M | +122.3% |
| R&D Expense | $21.0M | -16.7% |
| SG&A Expense | $137.7M | +9.6% |
| Operating Income | -$81.9M | +28.8% |
| Interest Expense | $15.3M | +113.4% |
| Income Tax | -$1.4M | — |
| Net Income | -$94.7M | +22.9% |
| EPS (Basic) | -$0.70 | +54.8% |
| EPS (Diluted) | -$0.70 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $122.0M | +81.3% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $30.8M | +76.6% |
| Inventory | $24.7M | +36.5% |
| Current Assets | $186.8M | +31.0% |
| Total Assets | $344.5M | +13.2% |
| Current Liabilities | $73.6M | -6.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$102.9M | -7.7% |
| Investing Cash Flow | $34.5M | -64.8% |
| Financing Cash Flow | $127.5M | +367.8% |
| +54.8% |
| Long-term Debt |
| $187.1M |
| +112.4% |
| Total Liabilities | $299.3M | +43.1% |
| Stockholders' Equity | $45.2M | -52.6% |